Show
Sort by
-
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
-
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer : a phase 1 dose-escalation and dose-expansion study
-
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
-
- Journal Article
- A1
- open access
Multidisciplinary molecular tumour board : a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
-
Pharmacokinetic effects and safety of olaparib administered with endocrine therapy : a phase I study in patients with advanced solid tumours
-
CD70 and PD-L1 in anaplastic thyroid cancer : promising targets for immunotherapy
-
- Journal Article
- A1
- open access
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
-
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies
-
Effect of itraconazole and rifampin on the pharmacokinetics of olaparib in patients with advanced solid tumors : results of two phase I open-label studies
-
Mesothelioma treatment: are we on target : a review